Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZBTB33
|
ENSG00000177485.6 | zinc finger and BTB domain containing 33 |
CHD2
|
ENSG00000173575.14 | chromodomain helicase DNA binding protein 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_93424671_93424945 | CHD2 | 1718 | 0.348904 | 0.88 | 1.9e-03 | Click! |
chr15_93477429_93477730 | CHD2 | 29876 | 0.169329 | 0.88 | 2.0e-03 | Click! |
chr15_93447765_93447916 | CHD2 | 137 | 0.606296 | 0.86 | 3.0e-03 | Click! |
chr15_93461331_93461622 | CHD2 | 13773 | 0.191343 | 0.82 | 6.3e-03 | Click! |
chr15_93465943_93466094 | CHD2 | 18315 | 0.186195 | 0.74 | 2.2e-02 | Click! |
chrX_119377644_119378130 | ZBTB33 | 6720 | 0.221485 | 0.64 | 6.3e-02 | Click! |
chrX_119384035_119384298 | ZBTB33 | 441 | 0.849316 | 0.62 | 7.2e-02 | Click! |
chrX_119385875_119386026 | ZBTB33 | 1340 | 0.473339 | 0.52 | 1.5e-01 | Click! |
chrX_119378294_119378445 | ZBTB33 | 6238 | 0.224289 | 0.50 | 1.7e-01 | Click! |
chrX_119385558_119385709 | ZBTB33 | 1023 | 0.574048 | 0.49 | 1.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_22833339_22833490 | 4.10 |
TUBGCP5 |
tubulin, gamma complex associated protein 5 |
19 |
0.98 |
chr16_3511461_3511696 | 1.99 |
NAA60 |
N(alpha)-acetyltransferase 60, NatF catalytic subunit |
3448 |
0.16 |
chr3_145878735_145878886 | 1.98 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
31 |
0.98 |
chr4_40057808_40058129 | 1.92 |
N4BP2 |
NEDD4 binding protein 2 |
478 |
0.8 |
chr19_33182720_33182871 | 1.85 |
NUDT19 |
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
72 |
0.96 |
chr15_48937816_48938257 | 1.83 |
FBN1 |
fibrillin 1 |
10 |
0.99 |
chr5_1445009_1445227 | 1.73 |
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter), member 3 |
427 |
0.87 |
chr14_20923516_20923667 | 1.68 |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
167 |
0.66 |
chr14_69256908_69257206 | 1.67 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
903 |
0.64 |
chr1_222885051_222885259 | 1.56 |
AIDA |
axin interactor, dorsalization associated |
615 |
0.45 |
chr11_85338949_85339118 | 1.55 |
TMEM126B |
transmembrane protein 126B |
596 |
0.48 |
chr10_50398424_50398575 | 1.53 |
C10orf128 |
chromosome 10 open reading frame 128 |
2063 |
0.33 |
chr17_47300618_47300769 | 1.51 |
PHOSPHO1 |
phosphatase, orphan 1 |
3430 |
0.18 |
chr14_99707290_99707521 | 1.43 |
AL109767.1 |
|
21880 |
0.2 |
chr19_18530764_18530945 | 1.43 |
SSBP4 |
single stranded DNA binding protein 4 |
59 |
0.94 |
chr16_2390606_2390757 | 1.43 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
55 |
0.95 |
chr9_79074751_79074902 | 1.42 |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
680 |
0.79 |
chr17_18585704_18585855 | 1.41 |
ZNF286B |
zinc finger protein 286B |
207 |
0.91 |
chrX_54384788_54385016 | 1.39 |
WNK3 |
WNK lysine deficient protein kinase 3 |
173 |
0.96 |
chr22_38597727_38597878 | 1.37 |
MAFF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
87 |
0.95 |
chr5_55957087_55957238 | 1.37 |
AC022431.2 |
Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. |
55103 |
0.14 |
chr20_44633733_44633884 | 1.35 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
3739 |
0.15 |
chr20_43247301_43247452 | 1.33 |
Z97053.1 |
Uncharacterized protein |
750 |
0.57 |
chr16_21312507_21312687 | 1.32 |
CRYM |
crystallin, mu |
1775 |
0.38 |
chr19_47733955_47734106 | 1.31 |
BBC3 |
BCL2 binding component 3 |
421 |
0.78 |
chr21_45658555_45658706 | 1.31 |
ICOSLG |
inducible T-cell co-stimulator ligand |
2093 |
0.2 |
chr9_88713988_88714176 | 1.30 |
GOLM1 |
golgi membrane protein 1 |
391 |
0.92 |
chr17_7476556_7476707 | 1.26 |
EIF4A1 |
eukaryotic translation initiation factor 4A1 |
3 |
0.89 |
chr12_58166434_58166585 | 1.25 |
METTL21B |
methyltransferase like 21B |
48 |
0.45 |
chr20_50807513_50807796 | 1.25 |
ZFP64 |
ZFP64 zinc finger protein |
582 |
0.86 |
chr1_24235612_24235949 | 1.23 |
RP11-4M23.3 |
|
2179 |
0.18 |
chr16_85419297_85419448 | 1.23 |
RP11-680G10.1 |
Uncharacterized protein |
28303 |
0.19 |
chr2_677678_677912 | 1.23 |
TMEM18 |
transmembrane protein 18 |
356 |
0.67 |
chr20_55965760_55966107 | 1.23 |
RBM38 |
RNA binding motif protein 38 |
530 |
0.69 |
chr10_72972089_72972259 | 1.22 |
UNC5B |
unc-5 homolog B (C. elegans) |
153 |
0.95 |
chr1_183774405_183774704 | 1.22 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
264 |
0.94 |
chr1_44872960_44873159 | 1.22 |
RNF220 |
ring finger protein 220 |
2099 |
0.3 |
chr19_9251341_9251492 | 1.20 |
ZNF317 |
zinc finger protein 317 |
343 |
0.82 |
chr1_1309817_1310047 | 1.20 |
AURKAIP1 |
aurora kinase A interacting protein 1 |
605 |
0.46 |
chr21_46294240_46294535 | 1.19 |
PTTG1IP |
pituitary tumor-transforming 1 interacting protein |
635 |
0.62 |
chr5_32710194_32710440 | 1.19 |
NPR3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
443 |
0.88 |
chr20_1757723_1757969 | 1.19 |
ENSG00000242348 |
. |
110840 |
0.05 |
chr6_44355096_44355314 | 1.16 |
CDC5L |
cell division cycle 5-like |
57 |
0.97 |
chr1_62902554_62902705 | 1.15 |
USP1 |
ubiquitin specific peptidase 1 |
303 |
0.93 |
chr22_45706313_45706504 | 1.12 |
FAM118A |
family with sequence similarity 118, member A |
403 |
0.85 |
chr15_44069336_44069487 | 1.12 |
ELL3 |
elongation factor RNA polymerase II-like 3 |
102 |
0.5 |
chr4_174450771_174450922 | 1.11 |
HAND2 |
heart and neural crest derivatives expressed 2 |
534 |
0.54 |
chr6_106442714_106442865 | 1.11 |
ENSG00000200198 |
. |
90541 |
0.08 |
chr7_5462062_5462269 | 1.10 |
TNRC18 |
trinucleotide repeat containing 18 |
1012 |
0.42 |
chr10_75118415_75118566 | 1.10 |
TTC18 |
tetratricopeptide repeat domain 18 |
46 |
0.96 |
chr19_54961094_54961375 | 1.09 |
LENG8 |
leukocyte receptor cluster (LRC) member 8 |
444 |
0.58 |
chr9_21802044_21802352 | 1.09 |
MTAP |
methylthioadenosine phosphorylase |
344 |
0.88 |
chr14_52535018_52535241 | 1.09 |
NID2 |
nidogen 2 (osteonidogen) |
583 |
0.79 |
chr8_108509562_108509962 | 1.09 |
ANGPT1 |
angiopoietin 1 |
476 |
0.9 |
chr10_15138945_15139096 | 1.08 |
RPP38 |
ribonuclease P/MRP 38kDa subunit |
159 |
0.67 |
chr22_39146873_39147412 | 1.08 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
823 |
0.37 |
chr3_14219692_14219843 | 1.07 |
LSM3 |
LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
91 |
0.77 |
chr2_214148731_214149018 | 1.06 |
SPAG16 |
sperm associated antigen 16 |
239 |
0.96 |
chr4_144256914_144257203 | 1.05 |
GAB1 |
GRB2-associated binding protein 1 |
857 |
0.62 |
chr14_61447473_61447652 | 1.05 |
TRMT5 |
tRNA methyltransferase 5 |
207 |
0.57 |
chrX_55516093_55516244 | 1.04 |
USP51 |
ubiquitin specific peptidase 51 |
533 |
0.8 |
chr20_44629926_44630077 | 1.03 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
7546 |
0.12 |
chr5_176816529_176816680 | 1.03 |
SLC34A1 |
solute carrier family 34 (type II sodium/phosphate contransporter), member 1 |
5159 |
0.1 |
chr1_201508309_201508460 | 1.03 |
CSRP1 |
cysteine and glycine-rich protein 1 |
29800 |
0.14 |
chr14_61124216_61124404 | 1.03 |
SIX1 |
SIX homeobox 1 |
667 |
0.74 |
chr19_14085122_14085273 | 1.02 |
DCAF15 |
DDB1 and CUL4 associated factor 15 |
14824 |
0.1 |
chr16_30007199_30007350 | 1.01 |
INO80E |
INO80 complex subunit E |
238 |
0.53 |
chr9_139553803_139553954 | 1.01 |
EGFL7 |
EGF-like-domain, multiple 7 |
570 |
0.48 |
chr2_219867757_219867920 | 0.99 |
AC097468.4 |
|
901 |
0.33 |
chr3_49940708_49940972 | 0.99 |
MST1R |
macrophage stimulating 1 receptor (c-met-related tyrosine kinase) |
202 |
0.76 |
chr6_84418476_84418627 | 0.99 |
SNAP91 |
synaptosomal-associated protein, 91kDa |
114 |
0.98 |
chr7_99006785_99006936 | 0.98 |
BUD31 |
BUD31 homolog (S. cerevisiae) |
259 |
0.6 |
chr14_76008304_76008525 | 0.98 |
BATF |
basic leucine zipper transcription factor, ATF-like |
19511 |
0.16 |
chr16_79879440_79879703 | 0.98 |
ENSG00000221330 |
. |
175937 |
0.03 |
chr6_11257576_11257964 | 0.98 |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
24855 |
0.22 |
chr9_94186812_94186963 | 0.98 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
743 |
0.78 |
chr3_50387939_50388090 | 0.97 |
CYB561D2 |
cytochrome b561 family, member D2 |
112 |
0.65 |
chr1_119683023_119683174 | 0.97 |
RP11-418J17.1 |
|
50 |
0.64 |
chr3_87040067_87040263 | 0.97 |
VGLL3 |
vestigial like 3 (Drosophila) |
92 |
0.99 |
chr1_29063026_29063177 | 0.96 |
YTHDF2 |
YTH domain family, member 2 |
32 |
0.98 |
chr10_118608848_118609018 | 0.96 |
ENO4 |
enolase family member 4 |
90 |
0.75 |
chr2_170441608_170441759 | 0.96 |
PPIG |
peptidylprolyl isomerase G (cyclophilin G) |
526 |
0.78 |
chr6_13575017_13575168 | 0.96 |
SIRT5 |
sirtuin 5 |
217 |
0.92 |
chr1_20811137_20811288 | 0.96 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
1501 |
0.42 |
chr3_194033211_194033441 | 0.96 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
38721 |
0.15 |
chr10_6342518_6342746 | 0.96 |
DKFZP667F0711 |
|
49646 |
0.13 |
chr4_186064331_186064482 | 0.95 |
SLC25A4 |
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
11 |
0.98 |
chr22_28007092_28007243 | 0.95 |
RP11-375H17.1 |
|
105301 |
0.08 |
chr5_73936955_73937237 | 0.95 |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
153 |
0.94 |
chr14_61448352_61448503 | 0.94 |
SLC38A6 |
solute carrier family 38, member 6 |
265 |
0.58 |
chr8_67940679_67940936 | 0.94 |
PPP1R42 |
protein phosphatase 1, regulatory subunit 42 |
21 |
0.97 |
chr2_1523098_1523249 | 0.94 |
TPO |
thyroid peroxidase |
15624 |
0.27 |
chr1_87381023_87381253 | 0.93 |
HS2ST1 |
heparan sulfate 2-O-sulfotransferase 1 |
781 |
0.5 |
chr19_1266927_1267078 | 0.93 |
CIRBP |
cold inducible RNA binding protein |
85 |
0.93 |
chr6_21596070_21596221 | 0.93 |
SOX4 |
SRY (sex determining region Y)-box 4 |
2074 |
0.5 |
chr19_55373573_55373724 | 0.92 |
ENSG00000199308 |
. |
6852 |
0.11 |
chr22_42662839_42662990 | 0.92 |
TCF20 |
transcription factor 20 (AR1) |
51466 |
0.12 |
chr10_29768886_29769037 | 0.92 |
SVIL |
supervillin |
16486 |
0.22 |
chr9_140503414_140503567 | 0.90 |
ARRDC1 |
arrestin domain containing 1 |
3335 |
0.15 |
chr16_3184119_3184321 | 0.89 |
RP11-473M20.14 |
|
608 |
0.36 |
chr17_47269941_47270115 | 0.89 |
GNGT2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
16246 |
0.14 |
chr16_89025471_89025640 | 0.89 |
CBFA2T3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
1372 |
0.35 |
chrX_52950600_52950792 | 0.89 |
FAM156B |
family with sequence similarity 156, member B |
22287 |
0.17 |
chr10_51371866_51372086 | 0.88 |
TIMM23B |
translocase of inner mitochondrial membrane 23 homolog B (yeast) |
540 |
0.51 |
chr9_139333406_139333557 | 0.88 |
INPP5E |
inositol polyphosphate-5-phosphatase, 72 kDa |
793 |
0.47 |
chrX_129299302_129299546 | 0.88 |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
214 |
0.94 |
chr19_39903487_39903974 | 0.87 |
PLEKHG2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
20 |
0.94 |
chr1_98386818_98386969 | 0.86 |
DPYD |
dihydropyrimidine dehydrogenase |
288 |
0.95 |
chr4_103997794_103997945 | 0.86 |
SLC9B2 |
solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 |
61 |
0.98 |
chr5_82769648_82769867 | 0.86 |
VCAN |
versican |
2013 |
0.46 |
chr14_75642618_75642769 | 0.85 |
TMED10 |
transmembrane emp24-like trafficking protein 10 (yeast) |
641 |
0.66 |
chr7_150102714_150102865 | 0.85 |
RP4-584D14.6 |
|
21816 |
0.11 |
chr7_5014125_5014276 | 0.85 |
RNF216P1 |
ring finger protein 216 pseudogene 1 |
487 |
0.77 |
chr16_79804143_79804372 | 0.85 |
ENSG00000221330 |
. |
100623 |
0.08 |
chr7_74508090_74508259 | 0.85 |
GTF2IRD2B |
GTF2I repeat domain containing 2B |
208 |
0.95 |
chr11_72295622_72295773 | 0.84 |
RP11-169D4.2 |
|
81 |
0.64 |
chr14_61789566_61789717 | 0.84 |
ENSG00000247287 |
. |
105 |
0.71 |
chr5_127872999_127873150 | 0.84 |
FBN2 |
fibrillin 2 |
440 |
0.61 |
chr7_74267960_74268143 | 0.84 |
GTF2IRD2 |
GTF2I repeat domain containing 2 |
204 |
0.94 |
chr11_68606378_68606529 | 0.84 |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
699 |
0.71 |
chr7_27219258_27219437 | 0.84 |
RP1-170O19.20 |
Uncharacterized protein |
285 |
0.59 |
chr10_104473554_104473705 | 0.84 |
ARL3 |
ADP-ribosylation factor-like 3 |
535 |
0.5 |
chr17_56402418_56402589 | 0.84 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
308 |
0.82 |
chr9_4297489_4297667 | 0.84 |
GLIS3 |
GLIS family zinc finger 3 |
918 |
0.55 |
chr13_44360193_44360351 | 0.84 |
ENOX1 |
ecto-NOX disulfide-thiol exchanger 1 |
772 |
0.76 |
chr20_37591297_37591479 | 0.83 |
DHX35 |
DEAH (Asp-Glu-Ala-His) box polypeptide 35 |
401 |
0.63 |
chr16_56703511_56703662 | 0.83 |
MT1H |
metallothionein 1H |
140 |
0.88 |
chr1_197918856_197919007 | 0.83 |
LHX9 |
LIM homeobox 9 |
32402 |
0.2 |
chr6_19804682_19804876 | 0.83 |
ID4 |
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
32838 |
0.2 |
chr4_120134399_120134650 | 0.83 |
USP53 |
ubiquitin specific peptidase 53 |
733 |
0.47 |
chr21_34914620_34914771 | 0.83 |
GART |
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase |
26 |
0.74 |
chr12_101674220_101674751 | 0.83 |
UTP20 |
UTP20, small subunit (SSU) processome component, homolog (yeast) |
598 |
0.77 |
chr5_92916417_92916950 | 0.83 |
ENSG00000237187 |
. |
30 |
0.98 |
chrX_107019456_107019640 | 0.83 |
TSC22D3 |
TSC22 domain family, member 3 |
60 |
0.96 |
chr1_1949942_1950093 | 0.82 |
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
763 |
0.52 |
chr2_182546095_182546262 | 0.82 |
NEUROD1 |
neuronal differentiation 1 |
575 |
0.69 |
chr17_16284077_16284327 | 0.82 |
UBB |
ubiquitin B |
43 |
0.96 |
chr2_175614351_175614502 | 0.82 |
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
14714 |
0.23 |
chr1_149783468_149783619 | 0.81 |
RP11-196G18.21 |
|
231 |
0.58 |
chr1_149398839_149398990 | 0.81 |
HIST2H2BB |
histone cluster 2, H2bb (pseudogene) |
265 |
0.81 |
chr1_6124012_6124163 | 0.81 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
17913 |
0.16 |
chr3_115342281_115342432 | 0.81 |
GAP43 |
growth associated protein 43 |
1 |
0.99 |
chr17_75315669_75315946 | 0.80 |
SEPT9 |
septin 9 |
123 |
0.97 |
chr1_145610669_145610820 | 0.80 |
POLR3C |
polymerase (RNA) III (DNA directed) polypeptide C (62kD) |
140 |
0.69 |
chr17_78712899_78713050 | 0.80 |
RP11-28G8.1 |
|
66458 |
0.11 |
chr8_11725838_11725997 | 0.80 |
CTSB |
cathepsin B |
179 |
0.94 |
chr10_79686644_79686795 | 0.80 |
DLG5 |
discs, large homolog 5 (Drosophila) |
341 |
0.54 |
chr5_73937413_73937691 | 0.80 |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
303 |
0.88 |
chr6_150336010_150336161 | 0.80 |
RAET1K |
retinoic acid early transcript 1K pseudogene |
9792 |
0.15 |
chr14_95601379_95601530 | 0.80 |
DICER1 |
dicer 1, ribonuclease type III |
1650 |
0.32 |
chr4_184365244_184365395 | 0.79 |
CDKN2AIP |
CDKN2A interacting protein |
425 |
0.84 |
chr17_2680360_2680552 | 0.79 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
106 |
0.96 |
chr1_245317007_245317219 | 0.79 |
KIF26B |
kinesin family member 26B |
1174 |
0.5 |
chr7_140373221_140373388 | 0.79 |
ADCK2 |
aarF domain containing kinase 2 |
315 |
0.61 |
chr14_105953591_105953742 | 0.79 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
412 |
0.72 |
chr19_17448552_17448811 | 0.79 |
GTPBP3 |
GTP binding protein 3 (mitochondrial) |
317 |
0.74 |
chr1_87379209_87379414 | 0.79 |
SEP15 |
Homo sapiens 15 kDa selenoprotein (SEP15), transcript variant 2, mRNA. |
498 |
0.67 |
chr19_9968157_9968686 | 0.78 |
OLFM2 |
olfactomedin 2 |
423 |
0.71 |
chr3_169379180_169379683 | 0.78 |
MECOM |
MDS1 and EVI1 complex locus |
1747 |
0.34 |
chr4_6927384_6927590 | 0.78 |
TBC1D14 |
TBC1 domain family, member 14 |
15512 |
0.16 |
chr14_61188562_61188752 | 0.78 |
SIX4 |
SIX homeobox 4 |
2195 |
0.33 |
chr22_20286360_20286577 | 0.78 |
XXbac-B444P24.13 |
|
19804 |
0.11 |
chr6_6587344_6587495 | 0.77 |
LY86-AS1 |
LY86 antisense RNA 1 |
7 |
0.96 |
chr8_38220315_38220786 | 0.77 |
WHSC1L1 |
Wolf-Hirschhorn syndrome candidate 1-like 1 |
17789 |
0.12 |
chr1_5831272_5831551 | 0.77 |
ENSG00000216045 |
. |
44608 |
0.17 |
chr6_150275548_150275738 | 0.77 |
ULBP1 |
UL16 binding protein 1 |
9500 |
0.13 |
chr11_10829296_10829447 | 0.77 |
EIF4G2 |
eukaryotic translation initiation factor 4 gamma, 2 |
52 |
0.95 |
chr19_38146875_38147026 | 0.77 |
ZFP30 |
ZFP30 zinc finger protein |
212 |
0.93 |
chr1_36557176_36557327 | 0.77 |
ADPRHL2 |
ADP-ribosylhydrolase like 2 |
2775 |
0.2 |
chr12_57637759_57637929 | 0.77 |
NDUFA4L2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
3369 |
0.12 |
chr2_219081424_219081657 | 0.76 |
ARPC2 |
actin related protein 2/3 complex, subunit 2, 34kDa |
277 |
0.86 |
chr6_130686691_130686851 | 0.76 |
TMEM200A |
transmembrane protein 200A |
108 |
0.64 |
chr2_27345818_27345969 | 0.76 |
ABHD1 |
abhydrolase domain containing 1 |
810 |
0.38 |
chr3_114865437_114865588 | 0.76 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
606 |
0.86 |
chr9_90166949_90167100 | 0.76 |
DAPK1-IT1 |
DAPK1 intronic transcript 1 (non-protein coding) |
1345 |
0.55 |
chr20_36322114_36322265 | 0.76 |
CTNNBL1 |
catenin, beta like 1 |
219 |
0.96 |
chr5_40680678_40680897 | 0.76 |
PTGER4 |
prostaglandin E receptor 4 (subtype EP4) |
1187 |
0.52 |
chr6_149888163_149888323 | 0.76 |
GINM1 |
glycoprotein integral membrane 1 |
813 |
0.49 |
chr16_733752_733964 | 0.75 |
JMJD8 |
jumonji domain containing 8 |
476 |
0.48 |
chr12_54393897_54394133 | 0.75 |
HOXC9 |
homeobox C9 |
112 |
0.62 |
chr5_137667166_137667465 | 0.75 |
CDC25C |
cell division cycle 25C |
168 |
0.93 |
chr17_77179648_77179799 | 0.75 |
RBFOX3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
169 |
0.96 |
chr14_74100317_74100543 | 0.75 |
RP3-414A15.10 |
|
52 |
0.96 |
chr14_102414954_102415194 | 0.75 |
DYNC1H1 |
dynein, cytoplasmic 1, heavy chain 1 |
15791 |
0.19 |
chr17_80605104_80605342 | 0.75 |
WDR45B |
WD repeat domain 45B |
1188 |
0.33 |
chr15_31774777_31774928 | 0.75 |
KLF13 |
Kruppel-like factor 13 |
116495 |
0.06 |
chr1_1982915_1983066 | 0.75 |
PRKCZ |
protein kinase C, zeta |
743 |
0.5 |
chr20_1358306_1358549 | 0.75 |
FKBP1A |
FK506 binding protein 1A, 12kDa |
15179 |
0.13 |
chr3_158289143_158289383 | 0.74 |
MLF1 |
myeloid leukemia factor 1 |
213 |
0.71 |
chr4_153960327_153960478 | 0.74 |
FHDC1 |
FH2 domain containing 1 |
96267 |
0.07 |
chr7_134001891_134002042 | 0.74 |
SLC35B4 |
solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4 |
163 |
0.97 |
chr1_10270059_10270210 | 0.74 |
KIF1B |
kinesin family member 1B |
729 |
0.64 |
chr3_38206210_38206361 | 0.73 |
OXSR1 |
oxidative stress responsive 1 |
711 |
0.63 |
chr9_100616468_100616619 | 0.73 |
FOXE1 |
forkhead box E1 (thyroid transcription factor 2) |
1007 |
0.57 |
chr12_4324911_4325447 | 0.73 |
CCND2 |
cyclin D2 |
57759 |
0.11 |
chr18_12420072_12420244 | 0.73 |
SLMO1 |
slowmo homolog 1 (Drosophila) |
142 |
0.95 |
chr16_2014100_2014251 | 0.73 |
RPS2 |
ribosomal protein S2 |
182 |
0.72 |
chr16_90148578_90148729 | 0.73 |
PRDM7 |
PR domain containing 7 |
6315 |
0.17 |
chr12_116713978_116714129 | 0.73 |
MED13L |
mediator complex subunit 13-like |
511 |
0.83 |
chr4_120548640_120548978 | 0.73 |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
21 |
0.99 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 4.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.4 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 1.5 | GO:0015853 | adenine transport(GO:0015853) |
0.4 | 1.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 1.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 0.9 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.3 | 0.9 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.3 | 0.8 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.7 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.2 | 0.7 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.9 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.6 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.6 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.6 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.8 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.2 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.2 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 1.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.2 | 0.5 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.2 | 0.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.5 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 2.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 0.3 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.2 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 3.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.2 | 0.6 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.6 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.4 | GO:0045901 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.1 | 0.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.4 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.6 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.4 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.4 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.1 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.5 | GO:0097531 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.5 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.4 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.7 | GO:1900087 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 1.0 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.4 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.1 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.6 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.2 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
0.1 | 0.1 | GO:0043369 | alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
0.1 | 0.5 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 1.1 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.2 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 0.5 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
0.1 | 0.4 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.3 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.5 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.1 | 0.3 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.5 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.2 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0045198 | polarized epithelial cell differentiation(GO:0030859) establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 1.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 1.1 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.4 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.2 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.3 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.8 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0060347 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.2 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.5 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.1 | GO:0002524 | hypersensitivity(GO:0002524) regulation of acute inflammatory response to antigenic stimulus(GO:0002864) regulation of hypersensitivity(GO:0002883) |
0.1 | 1.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.3 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.8 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.5 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.1 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.1 | 1.4 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.2 | GO:1901890 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.4 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 0.2 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.4 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 1.3 | GO:0006342 | chromatin silencing(GO:0006342) |
0.1 | 0.1 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.1 | 0.2 | GO:0060438 | trachea development(GO:0060438) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.2 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.2 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.1 | 0.6 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.4 | GO:0009219 | pyrimidine deoxyribonucleotide metabolic process(GO:0009219) |
0.1 | 1.0 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 0.2 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.1 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.6 | GO:0002209 | behavioral defense response(GO:0002209) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.5 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.4 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
0.1 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.1 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.3 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.1 | 0.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.0 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 2.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.3 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.4 | GO:0001508 | action potential(GO:0001508) |
0.0 | 0.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.2 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.7 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.1 | GO:0072401 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.4 | GO:0071326 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.0 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.6 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.1 | GO:0071514 | genetic imprinting(GO:0071514) |
0.0 | 0.7 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.0 | 0.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.9 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.0 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.7 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.0 | 1.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.2 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 1.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.0 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.1 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.0 | 0.1 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.0 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.0 | 1.1 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 2.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 2.2 | GO:0001666 | response to hypoxia(GO:0001666) |
0.0 | 0.0 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.0 | 0.3 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.2 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.5 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.8 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0019511 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.2 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0044320 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.0 | 0.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0014014 | negative regulation of gliogenesis(GO:0014014) |
0.0 | 0.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 0.1 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.2 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.2 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) |
0.0 | 0.2 | GO:0061053 | somite development(GO:0061053) |
0.0 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 3.2 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.5 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.2 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.2 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.0 | 0.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 1.4 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.8 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.5 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.0 | 0.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.7 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.3 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.3 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.0 | 0.0 | GO:0009265 | 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.0 | 0.0 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0010761 | fibroblast migration(GO:0010761) |
0.0 | 0.1 | GO:0050860 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.7 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.0 | 0.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.0 | 0.1 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.0 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.3 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.3 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.0 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0015992 | proton transport(GO:0015992) |
0.0 | 0.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.0 | GO:0035883 | enteroendocrine cell differentiation(GO:0035883) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 5.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0021684 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0001774 | microglial cell activation(GO:0001774) microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.0 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.0 | 0.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.0 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.0 | 0.0 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.0 | 0.2 | GO:0046131 | pyrimidine ribonucleoside metabolic process(GO:0046131) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.4 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.4 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.2 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.0 | 0.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.0 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.0 | 1.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.8 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.3 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.0 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.0 | 0.2 | GO:0000084 | mitotic S phase(GO:0000084) |
0.0 | 0.0 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.0 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.0 | 0.1 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.0 | 0.5 | GO:0000910 | cytokinesis(GO:0000910) |
0.0 | 0.0 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.4 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.6 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.0 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 1.8 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 1.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.0 | 0.1 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 1.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.0 | 0.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.3 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 1.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.0 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.6 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 2.3 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:1903038 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.0 | 0.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of calcium ion transmembrane transporter activity(GO:1901021) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) positive regulation of cation channel activity(GO:2001259) |
0.0 | 0.1 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.4 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.0 | 0.2 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.0 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.0 | 0.0 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.0 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.3 | GO:0034112 | positive regulation of homotypic cell-cell adhesion(GO:0034112) |
0.0 | 0.3 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 1.6 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.6 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.0 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.7 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.2 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 0.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.1 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.0 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.0 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0019692 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.0 | 0.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.0 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 1.0 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.0 | 0.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.0 | 0.0 | GO:0006312 | mitotic recombination(GO:0006312) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0048645 | organ formation(GO:0048645) |
0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 0.3 | GO:0046328 | regulation of JNK cascade(GO:0046328) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.4 | 2.2 | GO:0001527 | microfibril(GO:0001527) |
0.3 | 0.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 1.3 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 2.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.7 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.9 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.3 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.1 | 0.6 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.3 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.4 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 2.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.6 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 3.1 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 4.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.3 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 1.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.0 | 0.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.7 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 0.1 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 1.0 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 3.4 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.0 | 2.1 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 1.6 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 3.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.0 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 2.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 0.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 1.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 2.6 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 2.3 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 1.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 1.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0044304 | main axon(GO:0044304) |
0.0 | 1.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.0 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 2.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 4.6 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 1.1 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.0 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.2 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.0 | 0.6 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.2 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.2 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.2 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.1 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.0 | 3.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 3.4 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 15.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.6 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.0 | 0.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.8 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 4.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 48.5 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.7 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.0 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 1.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.5 | 1.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 1.4 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 0.9 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.3 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 0.8 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.3 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 1.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.8 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 1.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.7 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 2.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.8 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.4 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.5 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.4 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.4 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.7 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.1 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.9 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.2 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.9 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.1 | 4.5 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.1 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 1.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 1.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.2 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 1.8 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.7 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.0 | 1.7 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 0.1 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 1.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.2 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.0 | 1.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.3 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 1.5 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.6 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 2.2 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 1.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.1 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.2 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 1.6 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.6 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.0 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 1.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.2 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.7 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.2 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 5.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.4 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.8 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.9 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.0 | 1.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.2 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 1.4 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.0 | 1.0 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 1.8 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 1.8 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.0 | 0.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 1.2 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 0.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.0 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 2.0 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 1.7 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 1.3 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.0 | 0.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 2.1 | GO:0032561 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 6.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.9 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.0 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.5 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.5 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 1.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 23.8 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.0 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.2 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.5 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.0 | 0.2 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.0 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.8 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.0 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 1.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.4 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.0 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.5 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0005003 | ephrin receptor activity(GO:0005003) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 3.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 2.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 1.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.8 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 2.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.5 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 1.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 2.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 2.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 4.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 1.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.1 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 2.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.6 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 1.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 2.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.1 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.0 | 0.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 2.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 2.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 2.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.4 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 5.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.5 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.9 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.3 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.8 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 1.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |